Mallya, Akshat S.
Burrows, Tessa
Hsieh, Jeanne
Louwagie, Troy
Dutton, James R.
Ogle, Brenda M.
Hubel, Allison https://orcid.org/0000-0001-5856-0500
Funding for this research was provided by:
National Institutes of Health (R01HL154734)
Article History
Received: 3 October 2024
Accepted: 9 May 2025
First Online: 10 June 2025
Declarations
:
: The source lab obtained prior ethical approval from the University of Minnesota Human Subjects Research Institutional Review Board (IRB) for the collection of cells, with signed informed donor consent, and the derivation of the cell line used in this study []. The University of Minnesota does not require IRB oversight for using de-identified cell lines for research purposes. Hence, additional ethical approval was not required for the experiments performed in this study.
: Not applicable.
: AH declares a competing interest as she holds equity in Evia Bio Inc. which is related to the subject of this research. AH has issued patents # 10314302 and 20220240499, and an international patent application # PCT/US2020/029847 related to this work and owned by Regents of the University of Minnesota. The remaining authors declare that they have no competing interests.